US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kyverna Therapeutics

6.22

-0.3000-4.60%

Post-market: 6.250.0300+0.48%19:57 EDT

Volume:1.18M

Turnover:7.45M

Market Cap:384.67M

PE:-2.16

High:6.75

Open:6.62

Low:6.17

Close:6.52

52wk High:13.67

52wk Low:5.30

Shares:61.84M

Float Shares:39.72M

Volume Ratio:1.22

T/O Rate:2.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8809

EPS(LYR):-3.6445

ROE:-87.24%

ROA:-44.51%

PB:2.32

PE(LYR):-1.71

Loading ...

Overview Company News Filings

Press Release: Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Kyverna Therapeutics, Inc. Expected to Post a Loss of 68 Cents a Share - Earnings Preview

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Shares Rise on Manufacturing Deal for Autoimmune Disease Treatment

Kyverna Therapeutics, ElevateBio announce miv-cel manufacturing agreement

Kyverna Signs Commercial Manufacturing, Supply Deal with ElevateBio for Miv-cel CAR-T Therapy

Kyverna Therapeutics - Agreement Provides Scalable Miv-Cel Supply for Potential SPS and Gmg Launches

THOMSON REUTERS

Kyverna Therapeutics and Elevatebio Enter into Commercial Manufacturing and Supply Agreement for Miv-Cel

THOMSON REUTERS

Kyverna Therapeutics - on Track to Complete Rolling Bla Submission for Miv-Cel in SPS in Q4 2026

THOMSON REUTERS

Biotech Experts Want FDA Drug Reviews Based on Science, not Politics

Cue Biopharma Names Dominic Borie Chief Medical Officer, Head of R&D

Kyverna Therapeutics - Extends $15 Mln Term a Loan Availability Through Dec 31, 2026 - SEC Filing

THOMSON REUTERS

Kyverna Therapeutics appoints Ritesh Srivastava chief legal, compliance officer

Kyverna appoints Ritesh Srivastava as chief legal and compliance officer

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

THOMSON REUTERS

Health Rounds: CAR-T therapy brings hope to kidney patients with few transplant options

Sami Corwin Initiates Buy on Kyverna (KYTX) on Differentiated miv-cel Efficacy and Advancing BLA for First Autoimmune CAR T Approval

Kyverna Therapeutics Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Kyverna Therapeutics presents updated COMPARE trial data at EULAR

Kyverna says miv-cel CAR-T drives ACR70 response in Phase 1 trial in refractory ACPA-positive rheumatoid arthritis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/KYTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KYTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","market":"US","secType":"STK","nameCN":"Kyverna Therapeutics","latestPrice":6.22,"timestamp":1790971200000,"preClose":6.52,"halted":0,"volume":1183000,"hourTrading":{"tag":"盘后","latestPrice":6.25,"preClose":6.22,"latestTime":"19:57 EDT","volume":14379,"amount":89896.89,"timestamp":1790985464797,"change":0.03,"changeRate":0.004823,"amplitude":0.019293},"delay":0,"changeRate":-0.046012269938650284,"floatShares":39715000,"shares":61843444,"eps":-2.880877,"marketStatus":"Market Closed","change":-0.3,"latestTime":"10-02 16:00:00 EDT","open":6.62,"high":6.7537,"low":6.17,"amount":7454653.206,"amplitude":0.089525,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.880877,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1707368400000,"exchange":"NASDAQ","adjPreClose":6.52,"preHourTrading":{"tag":"盘前","latestPrice":6.63,"preClose":6.52,"latestTime":"09:29 EDT","volume":805,"amount":5290.703351499999,"timestamp":1790947799999,"change":0.11,"changeRate":0.016871,"amplitude":0.019939},"postHourTrading":{"tag":"盘后","latestPrice":6.25,"preClose":6.22,"latestTime":"19:57 EDT","volume":14379,"amount":89896.89,"timestamp":1790985464797,"change":0.03,"changeRate":0.004823,"amplitude":0.019293},"volumeRatio":1.215945,"impliedVol":1.4036,"impliedVolPercentile":0.6335},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","floatShares":39715000,"roa":"-44.51%","roe":"-87.24%","lyrEps":-3.644532,"volumeRatio":1.215945,"shares":61843444,"dividePrice":0,"high":6.7537,"amplitude":0.089525,"preClose":6.52,"low":6.17,"week52Low":5.3,"pbRate":"2.32","psRate":"1364.06","week52High":13.67,"institutionHeld":0,"latestPrice":6.22,"eps":-2.880877,"divideRate":0,"volume":1183000,"delay":0,"ttmEps":-2.880877,"open":6.62,"prevYearClose":9.4,"prevWeekClose":6.81,"prevMonthClose":6.8,"prevQuarterClose":6.8,"fiveDayClose":6.81,"twentyDayClose":8.35,"sixtyDayClose":9.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"KYTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-12","symbol":"KYTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-03-26","symbol":"KYTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.8,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2025-11-12","symbol":"KYTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.97,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-08-12","symbol":"KYTX","fiscalQuarterEnding":"2025/06","expectedEps":1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.97}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1755748800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYTX","date":"2026-10-01","current":-2.159065,"percent":0.546828,"low":-26.836094,"twenty":-4.176835,"median":-2.87436,"eighty":-1.131424,"high":-0.615209,"avg":-4.276681,"sd":5.577238,"marketCap":420535419},"quantilePoints":[{"date":"2024-02-09","current":-25.410847,"twenty":-24.055602,"median":-22.022734,"eighty":-19.989866,"marketCap":1224675750},{"date":"2024-02-16","current":-26.541682,"twenty":-26.641604,"median":-26.505996,"eighty":-25.427787,"marketCap":1279176368},{"date":"2024-02-23","current":-24.230994,"twenty":-26.541682,"median":-25.495549,"eighty":-24.578936,"marketCap":1167812779},{"date":"2024-03-01","current":-24.239916,"twenty":-26.505996,"median":-25.105309,"eighty":-24.54325,"marketCap":1168242754},{"date":"2024-03-08","current":-25.676289,"twenty":-26.318643,"median":-25.069622,"eighty":-24.578936,"marketCap":1237468769},{"date":"2024-03-15","current":-26.354329,"twenty":-26.354329,"median":-25.311608,"eighty":-24.712759,"marketCap":1270146888},{"date":"2024-03-22","current":-23.999034,"twenty":-26.354329,"median":-25.16776,"eighty":-24.239916,"marketCap":1156633422},{"date":"2024-03-28","current":-17.2201,"twenty":-26.32578,"median":-25.042858,"eighty":-23.820602,"marketCap":1039508532},{"date":"2024-04-05","current":-15.927342,"twenty":-26.311505,"median":-24.815357,"eighty":-20.313915,"marketCap":961469941},{"date":"2024-04-12","current":-17.062969,"twenty":-25.959995,"median":-24.578936,"eighty":-17.608641,"marketCap":1030023179},{"date":"2024-04-19","current":-13.577524,"twenty":-25.715544,"median":-24.235455,"eighty":-16.573007,"marketCap":819620788},{"date":"2024-04-26","current":-11.384836,"twenty":-25.597779,"median":-23.86521,"eighty":-16.071617,"marketCap":687256989},{"date":"2024-05-03","current":-10.734886,"twenty":-25.51207,"median":-23.093494,"eighty":-15.443094,"marketCap":648022117},{"date":"2024-05-10","current":-10.427767,"twenty":-25.427787,"median":-18.634621,"eighty":-13.461819,"marketCap":629482562},{"date":"2024-05-17","current":-8.660987,"twenty":-25.252064,"median":-17.663681,"eighty":-11.317698,"marketCap":657507471},{"date":"2024-05-24","current":-7.059414,"twenty":-25.176682,"median":-17.2201,"eighty":-10.732029,"marketCap":535922482},{"date":"2024-05-31","current":-7.116207,"twenty":-25.108877,"median":-16.627288,"eighty":-10.256351,"marketCap":540234007},{"date":"2024-06-07","current":-7.456968,"twenty":-25.053564,"median":-16.309455,"eighty":-9.030538,"marketCap":566103153},{"date":"2024-06-14","current":-5.412407,"twenty":-25.026799,"median":-16.020192,"eighty":-8.479248,"marketCap":410888275},{"date":"2024-06-21","current":-4.390126,"twenty":-24.958995,"median":-15.870204,"eighty":-7.953341,"marketCap":333280836},{"date":"2024-06-28","current":-4.259502,"twenty":-24.826956,"median":-14.259614,"eighty":-7.613717,"marketCap":323364330},{"date":"2024-07-05","current":-3.978375,"twenty":-24.748445,"median":-13.641804,"eighty":-7.429707,"marketCap":302022284},{"date":"2024-07-12","current":-5.56007,"twenty":-24.685994,"median":-12.649024,"eighty":-7.150283,"marketCap":422098238},{"date":"2024-07-19","current":-5.685015,"twenty":-24.571799,"median":-11.216991,"eighty":-6.028046,"marketCap":431583592},{"date":"2024-07-26","current":-5.588466,"twenty":-24.482583,"median":-10.813451,"eighty":-5.596417,"marketCap":424254000},{"date":"2024-08-02","current":-4.117518,"twenty":-24.238132,"median":-10.584898,"eighty":-5.421494,"marketCap":312585519},{"date":"2024-08-09","current":-3.725644,"twenty":-24.184602,"median":-9.999228,"eighty":-5.056881,"marketCap":282836000},{"date":"2024-08-16","current":-3.830678,"twenty":-23.972269,"median":-9.395703,"eighty":-4.700218,"marketCap":290809782},{"date":"2024-08-23","current":-4.597951,"twenty":-23.820602,"median":-8.80297,"eighty":-4.562778,"marketCap":349058032},{"date":"2024-08-30","current":-4.56385,"twenty":-23.561877,"median":-8.433813,"eighty":-4.558634,"marketCap":346469221},{"date":"2024-09-06","current":-4.171688,"twenty":-23.2407,"median":-8.189602,"eighty":-4.480996,"marketCap":316697893},{"date":"2024-09-13","current":-4.092119,"twenty":-22.946288,"median":-7.78069,"eighty":-4.395806,"marketCap":310657334},{"date":"2024-09-20","current":-3.631756,"twenty":-20.733738,"median":-7.624508,"eighty":-4.308092,"marketCap":275708384},{"date":"2024-09-27","current":-2.97247,"twenty":-18.634621,"median":-7.456968,"eighty":-4.211473,"marketCap":225658035},{"date":"2024-10-04","current":-2.63146,"twenty":-17.741488,"median":-7.394495,"eighty":-4.171688,"marketCap":199769924},{"date":"2024-10-11","current":-2.983837,"twenty":-17.707293,"median":-7.116207,"eighty":-4.052335,"marketCap":226520973},{"date":"2024-10-18","current":-3.205494,"twenty":-17.620069,"median":-6.641982,"eighty":-3.978375,"marketCap":243348245},{"date":"2024-10-25","current":-2.909952,"twenty":-17.56293,"median":-5.951944,"eighty":-3.964176,"marketCap":220911882},{"date":"2024-11-01","current":-2.779231,"twenty":-17.2201,"median":-5.608344,"eighty":-3.873307,"marketCap":210988106},{"date":"2024-11-08","current":-3.006571,"twenty":-17.062969,"median":-5.514635,"eighty":-3.751109,"marketCap":228246847},{"date":"2024-11-15","current":-1.697135,"twenty":-16.627288,"median":-5.392529,"eighty":-3.322005,"marketCap":187796512},{"date":"2024-11-22","current":-1.712741,"twenty":-16.355881,"median":-5.065967,"eighty":-3.177076,"marketCap":189523376},{"date":"2024-11-29","current":-2.251143,"twenty":-16.350167,"median":-4.969419,"eighty":-3.054313,"marketCap":249100201},{"date":"2024-12-06","current":-1.775165,"twenty":-16.285886,"median":-4.789428,"eighty":-3.003161,"marketCap":196430834},{"date":"2024-12-13","current":-1.724446,"twenty":-16.121613,"median":-4.674093,"eighty":-2.977017,"marketCap":190818525},{"date":"2024-12-20","current":-1.560584,"twenty":-16.033048,"median":-4.573541,"eighty":-2.950873,"marketCap":172686448},{"date":"2024-12-27","current":-1.556683,"twenty":-15.964482,"median":-4.562178,"eighty":-2.903132,"marketCap":172254731},{"date":"2025-01-03","current":-1.599599,"twenty":-15.904487,"median":-4.538274,"eighty":-2.797418,"marketCap":177003609},{"date":"2025-01-10","current":-1.346004,"twenty":-15.82735,"median":-4.480996,"eighty":-2.693979,"marketCap":148942061},{"date":"2025-01-17","current":-1.299186,"twenty":-15.443094,"median":-4.435561,"eighty":-2.615547,"marketCap":143761467},{"date":"2025-01-24","current":-1.404526,"twenty":-14.591731,"median":-4.395806,"eighty":-2.532048,"marketCap":155417803},{"date":"2025-01-31","current":-1.264073,"twenty":-13.927497,"median":-4.353211,"eighty":-2.095084,"marketCap":139876022},{"date":"2025-02-07","current":-1.170438,"twenty":-13.706085,"median":-4.259502,"eighty":-1.931223,"marketCap":129514836},{"date":"2025-02-14","current":-1.182143,"twenty":-13.577524,"median":-4.21845,"eighty":-1.814179,"marketCap":130809984},{"date":"2025-02-21","current":-1.084606,"twenty":-13.114702,"median":-4.187318,"eighty":-1.73693,"marketCap":120017081},{"date":"2025-02-28","current":-1.108015,"twenty":-12.719019,"median":-4.171688,"eighty":-1.688552,"marketCap":122607378},{"date":"2025-03-07","current":-1.01438,"twenty":-12.020501,"median":-4.104819,"eighty":-1.598038,"marketCap":112246191},{"date":"2025-03-14","current":-0.975365,"twenty":-11.480543,"median":-3.998252,"eighty":-1.555903,"marketCap":107929030},{"date":"2025-03-21","current":-0.928548,"twenty":-11.116285,"median":-3.978412,"eighty":-1.525471,"marketCap":102748436},{"date":"2025-03-28","current":-0.678003,"twenty":-10.923443,"median":-3.972766,"eighty":-1.481775,"marketCap":86429836},{"date":"2025-04-04","current":-0.671223,"twenty":-10.829164,"median":-3.959945,"eighty":-1.403746,"marketCap":85565537},{"date":"2025-04-11","current":-0.698343,"twenty":-10.750599,"median":-3.915931,"eighty":-1.33508,"marketCap":89022731},{"date":"2025-04-17","current":-0.630601,"twenty":-10.726315,"median":-3.836362,"eighty":-1.299186,"marketCap":80387103},{"date":"2025-04-25","current":-0.711969,"twenty":-10.557757,"median":-3.76816,"eighty":-1.283581,"marketCap":90759633},{"date":"2025-05-02","current":-0.772995,"twenty":-10.436338,"median":-3.711325,"eighty":-1.243785,"marketCap":98539030},{"date":"2025-05-09","current":-0.715359,"twenty":-10.170644,"median":-3.266591,"eighty":-1.184484,"marketCap":91191822},{"date":"2025-05-16","current":-0.68951,"twenty":-9.982087,"median":-3.188443,"eighty":-1.152492,"marketCap":100267785},{"date":"2025-05-23","current":-0.73409,"twenty":-9.837812,"median":-3.142975,"eighty":-1.119719,"marketCap":106750616},{"date":"2025-05-30","current":-0.781642,"twenty":-9.466412,"median":-3.049198,"eighty":-1.09553,"marketCap":113665635},{"date":"2025-06-06","current":-0.873775,"twenty":-9.030538,"median":-3.023622,"eighty":-1.030766,"marketCap":127063486},{"date":"2025-06-13","current":-1.02832,"twenty":-8.929052,"median":-2.986679,"eighty":-1.018767,"marketCap":149537300},{"date":"2025-06-20","current":-0.864859,"twenty":-8.793883,"median":-2.980995,"eighty":-1.008108,"marketCap":125766920},{"date":"2025-06-27","current":-1.031292,"twenty":-8.738225,"median":-2.966787,"eighty":-0.98785,"marketCap":149969489},{"date":"2025-07-03","current":-0.835139,"twenty":-8.660987,"median":-2.95542,"eighty":-0.975365,"marketCap":121445033},{"date":"2025-07-11","current":-1.061012,"twenty":-8.20664,"median":-2.912794,"eighty":-0.974824,"marketCap":154291376},{"date":"2025-07-18","current":-1.209614,"twenty":-8.200961,"median":-2.836066,"eighty":-0.975365,"marketCap":175900813},{"date":"2025-07-25","current":-1.260138,"twenty":-8.178243,"median":-2.779231,"eighty":-0.975365,"marketCap":183248021},{"date":"2025-08-01","current":-1.061012,"twenty":-7.803407,"median":-2.688295,"eighty":-0.975365,"marketCap":154291376},{"date":"2025-08-08","current":-0.98374,"twenty":-7.78069,"median":-2.625776,"eighty":-0.98374,"marketCap":143054469},{"date":"2025-08-15","current":-0.964666,"twenty":-7.68982,"median":-2.585992,"eighty":-0.974824,"marketCap":153089661},{"date":"2025-08-22","current":-0.975567,"twenty":-7.678462,"median":-2.530603,"eighty":-0.962936,"marketCap":154819487},{"date":"2025-08-29","current":-1.008267,"twenty":-7.570554,"median":-2.118493,"eighty":-0.964666,"marketCap":160008967},{"date":"2025-09-05","current":-0.989192,"twenty":-7.52512,"median":-1.993646,"eighty":-0.964666,"marketCap":156981771},{"date":"2025-09-12","current":-1.130894,"twenty":-7.468327,"median":-1.952681,"eighty":-0.972792,"marketCap":179469518},{"date":"2025-09-19","current":-1.365248,"twenty":-7.429707,"median":-1.872701,"eighty":-0.975257,"marketCap":216660791},{"date":"2025-09-26","current":-1.730404,"twenty":-7.422892,"median":-1.802474,"eighty":-0.975365,"marketCap":274609985},{"date":"2025-10-03","current":-1.656828,"twenty":-7.377457,"median":-1.775165,"eighty":-0.975365,"marketCap":262933655},{"date":"2025-10-10","current":-1.923883,"twenty":-7.30249,"median":-1.765048,"eighty":-0.975527,"marketCap":305314409},{"date":"2025-10-17","current":-1.910257,"twenty":-7.150283,"median":-1.79077,"eighty":-0.977747,"marketCap":303152125},{"date":"2025-10-24","current":-1.74403,"twenty":-7.070773,"median":-1.806706,"eighty":-0.98265,"marketCap":276772268},{"date":"2025-10-31","current":-1.839406,"twenty":-7.009436,"median":-1.817606,"eighty":-0.98374,"marketCap":291908252},{"date":"2025-11-07","current":-1.932058,"twenty":-6.429007,"median":-1.834596,"eighty":-0.986404,"marketCap":306611779},{"date":"2025-11-14","current":-1.76583,"twenty":-6.028046,"median":-1.829785,"eighty":-0.98707,"marketCap":280231922},{"date":"2025-11-21","current":-2.023973,"twenty":-5.954216,"median":-1.856881,"eighty":-0.988768,"marketCap":325843504},{"date":"2025-11-28","current":-2.086542,"twenty":-5.791787,"median":-1.873766,"eighty":-0.989487,"marketCap":335916623},{"date":"2025-12-05","current":-2.132789,"twenty":-5.650939,"median":-1.874832,"eighty":-0.990456,"marketCap":343361972},{"date":"2025-12-12","current":-2.27425,"twenty":-5.604368,"median":-1.895008,"eighty":-0.995653,"marketCap":366135981},{"date":"2025-12-19","current":-1.904276,"twenty":-5.571428,"median":-1.899357,"eighty":-1.000453,"marketCap":306573190},{"date":"2025-12-26","current":-2.445634,"twenty":-5.541896,"median":-1.907532,"eighty":-1.00316,"marketCap":393727568},{"date":"2026-01-02","current":-3.335677,"twenty":-5.503276,"median":-1.923883,"eighty":-1.005937,"marketCap":537017328},{"date":"2026-01-09","current":-2.998561,"twenty":-5.448754,"median":-1.93164,"eighty":-1.007666,"marketCap":482744300},{"date":"2026-01-16","current":-3.094373,"twenty":-5.404456,"median":-1.947802,"eighty":-1.008709,"marketCap":498169266},{"date":"2026-01-23","current":-3.729571,"twenty":-5.372651,"median":-1.953858,"eighty":-1.010478,"marketCap":600431076},{"date":"2026-01-30","current":-2.913395,"twenty":-5.344255,"median":-1.965361,"eighty":-1.010992,"marketCap":469033219},{"date":"2026-02-06","current":-2.579827,"twenty":-5.065967,"median":-1.978384,"eighty":-1.01346,"marketCap":415331486},{"date":"2026-02-13","current":-2.611764,"twenty":-5.054609,"median":-2.003915,"eighty":-1.013717,"marketCap":420473142},{"date":"2026-02-20","current":-2.87436,"twenty":-4.986457,"median":-2.025703,"eighty":-1.014247,"marketCap":462748974},{"date":"2026-02-27","current":-2.881457,"twenty":-4.928528,"median":-2.043785,"eighty":-1.01438,"marketCap":463891564},{"date":"2026-03-06","current":-2.977269,"twenty":-4.827435,"median":-2.086542,"eighty":-1.020777,"marketCap":479316530},{"date":"2026-03-13","current":-3.112116,"twenty":-4.780255,"median":-2.118493,"eighty":-1.024754,"marketCap":501025741},{"date":"2026-03-20","current":-3.030498,"twenty":-4.769593,"median":-2.129165,"eighty":-1.025937,"marketCap":487885955},{"date":"2026-03-27","current":-3.012142,"twenty":-4.692966,"median":-2.151832,"eighty":-1.027873,"marketCap":484930840},{"date":"2026-04-02","current":-3.286851,"twenty":-4.628408,"median":-2.225282,"eighty":-1.029368,"marketCap":530192007},{"date":"2026-04-10","current":-3.590425,"twenty":-4.584311,"median":-2.250455,"eighty":-1.030802,"marketCap":579160710},{"date":"2026-04-17","current":-3.571686,"twenty":-4.573206,"median":-2.388506,"eighty":-1.03519,"marketCap":576137951},{"date":"2026-04-24","current":-3.358479,"twenty":-4.567056,"median":-2.487395,"eighty":-1.037789,"marketCap":541746122},{"date":"2026-05-01","current":-3.302191,"twenty":-4.561844,"median":-2.543569,"eighty":-1.038061,"marketCap":532666578},{"date":"2026-05-08","current":-3.489816,"twenty":-4.559102,"median":-2.569768,"eighty":-1.044783,"marketCap":562931724},{"date":"2026-05-15","current":-4.15662,"twenty":-4.534296,"median":-2.581654,"eighty":-1.052413,"marketCap":650095346},{"date":"2026-05-22","current":-3.444499,"twenty":-4.49595,"median":-2.613087,"eighty":-1.058444,"marketCap":538719607},{"date":"2026-05-29","current":-3.347743,"twenty":-4.480996,"median":-2.625776,"eighty":-1.061012,"marketCap":523587034},{"date":"2026-06-05","current":-3.076828,"twenty":-4.471909,"median":-2.688295,"eighty":-1.061714,"marketCap":481215829},{"date":"2026-06-12","current":-3.045866,"twenty":-4.449191,"median":-2.698705,"eighty":-1.063858,"marketCap":476373405},{"date":"2026-06-18","current":-3.11166,"twenty":-4.431665,"median":-2.713919,"eighty":-1.066038,"marketCap":486663555},{"date":"2026-06-26","current":-3.187473,"twenty":-4.412024,"median":-2.725319,"eighty":-1.06856,"marketCap":498520738},{"date":"2026-07-02","current":-3.280765,"twenty":-4.395806,"median":-2.779231,"eighty":-1.069929,"marketCap":513111589},{"date":"2026-07-10","current":-3.813306,"twenty":-4.390126,"median":-2.789213,"eighty":-1.073668,"marketCap":596401029},{"date":"2026-07-17","current":-2.892048,"twenty":-4.36173,"median":-2.806937,"eighty":-1.084606,"marketCap":452316377},{"date":"2026-07-24","current":-2.833741,"twenty":-4.344692,"median":-2.815944,"eighty":-1.092409,"marketCap":443197095},{"date":"2026-07-31","current":-2.911484,"twenty":-4.315412,"median":-2.817583,"eighty":-1.094857,"marketCap":455356137},{"date":"2026-08-07","current":-3.01255,"twenty":-4.26922,"median":-2.824699,"eighty":-1.099263,"marketCap":471162893},{"date":"2026-08-14","current":-3.273726,"twenty":-4.239266,"median":-2.836847,"eighty":-1.106454,"marketCap":499695027},{"date":"2026-08-21","current":-3.293984,"twenty":-4.227182,"median":-2.842423,"eighty":-1.108015,"marketCap":502787199},{"date":"2026-08-28","current":-3.500618,"twenty":-4.222326,"median":-2.869037,"eighty":-1.115418,"marketCap":534327356},{"date":"2026-09-04","current":-3.383121,"twenty":-4.213489,"median":-2.87436,"eighty":-1.117439,"marketCap":516392757},{"date":"2026-09-11","current":-2.977956,"twenty":-4.201242,"median":-2.881457,"eighty":-1.123506,"marketCap":454549313},{"date":"2026-09-18","current":-2.852356,"twenty":-4.185897,"median":-2.878979,"eighty":-1.129545,"marketCap":435377845},{"date":"2026-09-25","current":-2.832097,"twenty":-4.18008,"median":-2.881457,"eighty":-1.131212,"marketCap":432285673},{"date":"2026-10-01","current":-2.755116,"twenty":-4.176835,"median":-2.87436,"eighty":-1.131424,"marketCap":420535419}],"updateTime":1791014069666},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658948500","title":"Press Release: Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948500","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948500?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:02","pubTimestamp":1786478520,"startTime":"0","endTime":"0","summary":"-- Kyverna has initiated its rolling BLA, submitted the Chemistry,Manufacturing and Controls  module and is on track to. complete its submission in the fourth quarter of 2026.-- The Company plans to seek priority review, under the Regenerative. -- Kyverna continues to advance activities to enable a successful. rare disease launch in SPS upon approval. These efforts include. hiring key commercial leadership roles, commercial site activation,a commercial supply agreement, payer and patient advocacy. -- The Company plans to report 12-month topline data from KYSA-8 in. -- Enrollment Ongoing in KYSA-6 Registrational Trial for gMG:. -- Kyverna continues to advance its Phase 3 gMG trial and expects to. complete enrollment by mid-2027. The Company anticipates sharing. longer-term follow-up Phase 2 topline data in Q3 2026.-- Advancing Progressive Multiple Sclerosis  Strategy with RMAT. Designation Granted for Miv-cel for Treatment of No","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443978.SGD","IE00BZ1G4Q59.USD","LU0170899867.USD","LU2237443549.SGD","IE00B1BXHZ80.USD","LU2746668974.SGD","IE00BKVL7J92.USD","LU0149725797.USD","KYTX","LU2746668461.USD","CMC","LU0267386448.USD","LU2237443465.HKD","IE00BHPRN162.USD","LU2065732104.USD","BK4139","LU0882574139.USD","LU2237443895.HKD","LU1363072403.SGD","IE00BFXG1179.USD","LU2237443622.USD","BK4006","LU0971096721.USD","PRGS","BK4097","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643484","title":"Kyverna Therapeutics, Inc. Expected to Post a Loss of 68 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643484","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643484?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:08","pubTimestamp":1786104487,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics, Inc. <KYTX.OQ> expected to post a loss of68cents a share - Earnings PreviewKyverna Therapeutics, Inc.KYTX.OQKYTX.Ois expected to  show no change in quarterly revenue when it repo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N444155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654424690","title":"Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Kyverna Therapeutics, Inc. (KYTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654424690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654424690?lang=en_us&edition=fundamental","pubTime":"2026-07-28 02:00","pubTimestamp":1785175245,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eli Lilly & Co (LLY) and Kyverna Therapeutics, Inc. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-eli-lilly-co-lly-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-eli-lilly-co-lly-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2462157665.USD","BK4516","LU0133085943.USD","LU2087625088.SGD","BK4585","LU1366192091.USD","LU2552382132.HKD","LU2213496289.HKD","LU2602419157.SGD","LU2361045086.USD","LU2896262040.SGD","LU2028103732.USD","GB00BDT5M118.USD","LU0256863902.USD","BK4588","LU0432979614.USD","LU0943347566.SGD","LU1814569148.SGD","LU2756315318.SGD","LU0109391861.USD","LU1145028129.USD","LU1868836591.USD","IE00B7KXQ091.USD","LU1868836914.USD","LU2168563687.JPY","PPH","SG9999017495.SGD","BK4599","LU2168564149.EUR","LU2756315664.SGD","LU0114720955.EUR","LU0266013472.USD","LU0256863811.USD","IE00B775H168.HKD","LU1983299246.USD","LU1061106388.HKD","LU2063271972.USD","LU2089984988.USD","SG9999015945.SGD","LU1629891620.HKD","WDNA","LU0823416689.USD","LU0061475181.USD","LU0471298694.HKD","SGXZ31699556.SGD","LU2746668974.SGD","LU1127390331.HKD","LU2112291526.USD","IE0005OL40V9.USD","LU1057294990.SGD","FHLC","LU0079474960.USD","TRUH","LU0289739699.SGD","IYH","LU0174119429.USD","LU1551013342.USD","LU2106854487.HKD","LU2168564222.USD","SG9999013999.USD","FTXH","CANC","LU0787776722.HKD","LU1551013425.SGD","BK4139","MEDI","SG9999014880.SGD","LU2271345857.HKD","IE00BK4W5M84.HKD","LU2237443895.HKD","LU1917777945.USD","LU2462591350.SGD","LU1280957306.USD","LU2237438978.USD","LU2417539215.USD","LU1988902786.USD","JDOC","SG9999014914.USD","IE0001KFT4U8.USD","IE00BWXC8680.SGD","LU2237443465.HKD","LU0203202063.USD","LU1093756325.SGD","LU0234572021.USD","LU2089284900.SGD","LU2471134796.USD","LU0823434583.USD","LU0456855351.SGD","LU2361044865.SGD","LU0094547139.USD","LU2023250330.USD","LU1232071149.USD","LU0823434740.USD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU2491049909.HKD","LU0345770308.USD","SG9999015952.SGD","LU2168564495.EUR","RXL","LU0198837287.USD","IE0004445015.USD","LU1093756168.USD","LU2265009873.SGD","SGXZ57979304.SGD","LU0353189763.USD","IE00B4JS1V06.HKD","IE00BKDWB100.SGD","CURE","IE0009355771.USD","LU2552382215.SGD","LU1064131342.USD","GDOC","LU2491050071.SGD","LU2108987350.USD","LU1989771016.USD","LU0786609619.USD","LU0323591593.USD","LU0889565916.HKD","LU0006306889.USD","LU0820562030.AUD","LU2237443622.USD","IE00BN29S564.USD","LU1804176565.USD","LU0320765992.SGD","LU1712237335.SGD","AGNG","SG9999014898.SGD","SG9999018865.SGD","IE00BKPKM429.USD","ILDR","LLYZ","ELIL","LU2552382058.USD","SG9999014906.USD","LU2237443978.SGD","LU0683600562.USD","LU0882574055.USD","LU2023251221.USD","SG9999001176.SGD","LU2746668461.USD","IE0004445239.USD","IE00BJJMRY28.SGD","LU1720051108.HKD","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU0345770993.USD","LU1023059063.AUD","LU2237443382.USD","MHIP","LU0225283273.USD","LU0964807845.USD","IE00BJT1NW94.SGD","MEDX","LU0820561909.HKD","IE00B4R5TH58.HKD","LU2471134523.USD","SG9999015986.USD","LU1623119135.USD","LU2168564065.EUR","LU2468319806.SGD","LU2089283258.USD","IXJ","IE00BFTCPJ56.SGD","LU0354030438.USD","LU0158827781.USD","LU2237443549.SGD","LU1868836757.USD","LU2324357040.USD","THNR","LU0106261372.USD","BK4533","OZEM","LU0672654240.SGD","LU0097036916.USD","LU0689472784.USD","SG9999001176.USD","IE00BK4W5L77.USD","BK4581","KYTX","LU0466842654.USD","IHE","LU0058720904.USD","LLII","IE00BJJMRZ35.SGD","VHT","ELIS","BK4007","LU1291159041.SGD","LU0820561818.USD","LU0316494557.USD","IE00BJLML261.HKD","LU2357305700.SGD","LU2750360997.AUD","LU0158827948.USD","LU1323610961.USD","LU0882574139.USD","LU2456880835.USD","LU0122379950.USD","SG9999018857.SGD","LLYX","IE00BFSS7M15.SGD","LU0320765059.SGD","LU0417517546.SGD","LU0471298777.SGD","LU0238689110.USD","LU1868837300.USD","LU1974910355.USD","LU0354030511.USD","LU2750360641.GBP","LU0353189680.USD","LU0203201768.USD","SGXZ51526630.SGD","LU1035775433.USD","PJP","IE00BJJMRX11.SGD","HRTS","IE0002141913.USD","LU0210536198.USD","LU1069344957.HKD","LLY","LU0640476718.USD","LU2360106947.USD","LU2471134952.CNY","LU0385154629.USD","LU1868837136.USD","LU2236285917.USD","SG9999015978.USD","SGXZ81514606.USD","LU2023250504.SGD","LU0708995401.HKD","LU2211815571.USD","LU0109394709.USD","LU2471134879.HKD","LU2491050154.USD","LU2264538146.SGD","TMED","IE00BFSS8Q28.SGD","LU2111349929.HKD","IE00B1XK9C88.USD","LU2361044949.HKD","LU1720051017.SGD","LU1548497426.USD","LU1267930730.SGD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654206046","title":"Kyverna Therapeutics Shares Rise on Manufacturing Deal for Autoimmune Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2654206046","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654206046?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:53","pubTimestamp":1785163980,"startTime":"0","endTime":"0","summary":"Shares of Kyverna Therapeutics rose after the company struck a commercial manufacturing and supply deal with ElevateBio for miv-cel, a patient-cell treatment in development for autoimmune diseases, including stiff person syndrome and generalized myasthenia gravis.Shares were recently up about 6% at $7.83 in late morning trading. The stock is down about 18% over the past three monthsThe agreement covers U.S. commercial and global clinical supply of miv-cel. The late-stage clinical biopharmaceutical company said the deal provides flexible, scalable supply to support potential launches in stiff person syndrome and generalized myasthenia gravis.The companies said their partnership has delivered a clinical manufacturing success rate of more than 98% for miv-cel.Kyverna said it remains on track to complete its rolling BLA submission for stiff person syndrome in the fourth quarter. The company said mivcel could become the first FDA approved CAR T-cell therapy for an autoimmune disease and the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Kyverna Therapeutics Shares Rise on Manufacturing Deal for Autoimmune Disease Treatment","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010580","title":"Kyverna Therapeutics, ElevateBio announce miv-cel manufacturing agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010580","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010580?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:11","pubTimestamp":1785154293,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics (KYTX) and ElevateBio announced a manufacturing agreement for both U.S. commercial and global clinical supply of miv-cel, Kyve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-elevatebio-announce-miv-cel-manufacturing-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-elevatebio-announce-miv-cel-manufacturing-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EES","BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654179270","title":"Kyverna Signs Commercial Manufacturing, Supply Deal with ElevateBio for Miv-cel CAR-T Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654179270","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654179270?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:03","pubTimestamp":1785153818,"startTime":"0","endTime":"0","summary":"Kyverna signs commercial manufacturing, supply deal with ElevateBio for miv-cel CAR-T therapyKyverna signed a commercial manufacturing and supply agreement with ElevateBio for miv-cel, covering U.S. c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL3nKBvr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654378017","title":"Kyverna Therapeutics - Agreement Provides Scalable Miv-Cel Supply for Potential SPS and Gmg Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=2654378017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654378017?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:00","pubTimestamp":1785153605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA1TGB1L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654173210","title":"Kyverna Therapeutics and Elevatebio Enter into Commercial Manufacturing and Supply Agreement for Miv-Cel","url":"https://stock-news.laohu8.com/highlight/detail?id=2654173210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654173210?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:00","pubTimestamp":1785153605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA1TGB1L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654017317","title":"Kyverna Therapeutics - on Track to Complete Rolling Bla Submission for Miv-Cel in SPS in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654017317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654017317?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:00","pubTimestamp":1785153605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA1TGB1L:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653769792","title":"Biotech Experts Want FDA Drug Reviews Based on Science, not Politics","url":"https://stock-news.laohu8.com/highlight/detail?id=2653769792","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653769792?lang=en_us&edition=fundamental","pubTime":"2026-07-22 23:31","pubTimestamp":1784734300,"startTime":"0","endTime":"0","summary":"UPDATE 1-Biotech experts want FDA drug reviews based on science, not politicsBiotech investors want regulatory predictabilityMore than 3,000 FDA jobs were cut by DOGEFDA now authorized to hire 2,200 e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL1N43O0R8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4532","MRNY","MRNX","BK4139","IDNA","BK4505","GNOM","BK4533","WDNA","MRNA","BK4534","BK4568","LGHT","BK4588","BK4551","NKTX","BK4585","BK4548","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114292","title":"Cue Biopharma Names Dominic Borie Chief Medical Officer, Head of R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114292","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114292?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:17","pubTimestamp":1783948641,"startTime":"0","endTime":"0","summary":"Cue Biopharma names Dominic Borie chief medical officer, head of R&DCue Biopharma named Dominic Borie as chief medical officer, head of research and development, reporting to CEO Shao-Lee Lin.Borie wa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDLb1kn5y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2089984988.USD","CUE","PBE","IE00BN0W2T93.GBP","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU2210150020.SGD","LU0314104364.USD","LU2112291526.USD","SG9999014021.USD","BBH","IE00BGHQF748.EUR","IE0009355771.USD","LU2242652126.USD","SG9999014039.USD","BIB","BK4566","LU0109394709.USD","KYTX","LU2242646821.SGD","BK4585","LU2095319765.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4112","BK4139","IE00B64PRP62.GBP","IBB","LU0889565916.HKD","LU1983299246.USD","IE00BN0W2W23.USD","LU1057294990.SGD","PJP","LU0868494617.USD","IBBQ","IE00B3QW5Z07.USD","LU0289739699.SGD","NDAQ","LU2210149790.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0002141913.USD","BK4533","SG9999001440.SGD","LU0058720904.USD","LU1023059063.AUD","AMGN","IE00B2B36J28.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650313923","title":"Kyverna Therapeutics - Extends $15 Mln Term a Loan Availability Through Dec 31, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2650313923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650313923?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:06","pubTimestamp":1783591606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43A184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645223180","title":"Kyverna Therapeutics appoints Ritesh Srivastava chief legal, compliance officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2645223180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645223180?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:11","pubTimestamp":1782130274,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics (KYTX) announced the appointment of Ritesh Srivastava as chief legal and compliance officer, effective June 22. Srivastava bri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-appoints-ritesh-srivastava-chief-legal-compliance-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-appoints-ritesh-srivastava-chief-legal-compliance-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645902466","title":"Kyverna appoints Ritesh Srivastava as chief legal and compliance officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2645902466","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645902466?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:01","pubTimestamp":1782129703,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics appointed Ritesh Srivastava as chief legal and compliance officer, effective June 22, 2026.Move supports its transition toward commercialization as it advances miv-cel toward a potential first approval in stiff person syndrome.Srivastava most recently served as general counsel at BPGbio, advising on R&D, commercialization planning, and operations.He previously held senior compliance roles at Spectrum Pharmaceuticals and Avanir Pharmaceuticals, following earlier work as a federal prosecutor.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL3rBHb9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","KYTX","BK4139","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024559","title":"Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024559","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024559?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:00","pubTimestamp":1782129603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUABJ5S5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641642781","title":"Health Rounds: CAR-T therapy brings hope to kidney patients with few transplant options","url":"https://stock-news.laohu8.com/highlight/detail?id=2641642781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641642781?lang=en_us&edition=fundamental","pubTime":"2026-06-05 03:53","pubTimestamp":1780602793,"startTime":"0","endTime":"0","summary":"Health Rounds: CAR-T therapy brings hope to kidney patients with few transplant optionsHealth Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us?Forward this newsletter to them. They can also subscribe hereBy Nancy LapidJune 4  - Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nL1N42C0TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640864461","title":"Sami Corwin Initiates Buy on Kyverna (KYTX) on Differentiated miv-cel Efficacy and Advancing BLA for First Autoimmune CAR T Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2640864461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640864461?lang=en_us&edition=fundamental","pubTime":"2026-06-04 02:16","pubTimestamp":1780510572,"startTime":"0","endTime":"0","summary":"William Blair analyst Sami Corwin has maintained their bullish stance on KYTX stock, giving a Buy rating today. Sami Corwin has given his Buy ratin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sami-corwin-initiates-buy-on-kyverna-kytx-on-differentiated-miv-cel-efficacy-and-advancing-bla-for-first-autoimmune-car-t-approval-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sami-corwin-initiates-buy-on-kyverna-kytx-on-differentiated-miv-cel-efficacy-and-advancing-bla-for-first-autoimmune-car-t-approval-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYTX","BK4139","BK4022","BK4230","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640185385","title":"Kyverna Therapeutics Price Target Maintained With a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2640185385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640185385?lang=en_us&edition=fundamental","pubTime":"2026-06-04 00:23","pubTimestamp":1780503780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 03, 2026 12:23 ET (16:23 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640890266","title":"Kyverna Therapeutics presents updated COMPARE trial data at EULAR","url":"https://stock-news.laohu8.com/highlight/detail?id=2640890266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640890266?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:00","pubTimestamp":1780491642,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics (KYTX) announced the presentation of updated data from the Phase 1 portion of COMPARE, a Phase 1/2 investigator-initiated tria...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-presents-updated-compare-trial-data-at-eular-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kyverna-therapeutics-presents-updated-compare-trial-data-at-eular-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640649901","title":"Kyverna says miv-cel CAR-T drives ACR70 response in Phase 1 trial in refractory ACPA-positive rheumatoid arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2640649901","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640649901?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:00","pubTimestamp":1780488045,"startTime":"0","endTime":"0","summary":"Kyverna highlighted updated Phase 1 COMPARE trial results for miv-cel in ACPA-positive, treatment-refractory rheumatoid arthritis, presented at EULAR 2026.Patients showed broad clinical improvement following a single infusion, supporting potential for meaningful disease control in a hard-to-treat population.Findings also pointed to durable suppression of disease-related immune activity while preserving protective vaccine immunity, consistent with an immune “reset” effect.Safety remained consistent with prior experience, with no severe cytokine release syndrome or neurotoxicity reported in the Phase 1 cohort.The randomized Phase 2 portion comparing miv-cel with rituximab has started and is fully enrolled, setting up a key read-through for differentiation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9f4hY4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","NDAQ","SG9999014021.USD","BK4112","BK4585","BK4588","SG9999014039.USD","BK4139","IE00B3QW5Z07.USD","KYTX","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2095319765.USD","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BGHQF748.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":89,"code":"91000000","status":"200"}]}}